Skip to Main Content

Paper Details

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors.
bioRxiv
0
2023
Author NameAffiliation
Junko TsujiBroad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Nicholas J HaradhvalaBroad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Gad GetzHarvard Medical School
Gad GetzBroad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Gad GetzMassachusetts General Hospital
Gad GetzHarvard Medical School
Gad GetzBroad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Gad GetzMassachusetts General Hospital
  • 1 - 8

Datasets

Release 1.2